These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38051221)

  • 21. Correlation NKX2.2 IHC and
    Pasricha S; Pahwa S; Pruthi M; Jajodia A; Gupta G; Sharma A; Durga G; Kamboj M; Tiwari A; Panigrahi M; Mehta A
    Indian J Pathol Microbiol; 2023; 66(1):58-62. PubMed ID: 36656211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting Tumor Vascular CD99 Inhibits Tumor Growth.
    Huijbers EJM; van der Werf IM; Faber LD; Sialino LD; van der Laan P; Holland HA; Cimpean AM; Thijssen VLJL; van Beijnum JR; Griffioen AW
    Front Immunol; 2019; 10():651. PubMed ID: 31001265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical detection of EWS and FLI-1 proteinss in Ewing sarcoma and primitive neuroectodermal tumors: comparative analysis with CD99 (MIC-2) expression.
    Llombart-Bosch A; Navarro S
    Appl Immunohistochem Mol Morphol; 2001 Sep; 9(3):255-60. PubMed ID: 11556754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of Wnt/β-Catenin in Ewing Sarcoma Cells Antagonizes EWS/ETS Function and Promotes Phenotypic Transition to More Metastatic Cell States.
    Pedersen EA; Menon R; Bailey KM; Thomas DG; Van Noord RA; Tran J; Wang H; Qu PP; Hoering A; Fearon ER; Chugh R; Lawlor ER
    Cancer Res; 2016 Sep; 76(17):5040-53. PubMed ID: 27364557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-214-3p Is Commonly Downregulated by EWS-FLI1 and by CD99 and Its Restoration Limits Ewing Sarcoma Aggressiveness.
    De Feo A; Pazzaglia L; Ciuffarin L; Mangiagli F; Pasello M; Simonetti E; Pellegrini E; Ferrari C; Bianchi G; Spazzoli B; Scotlandi K
    Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversible LSD1 inhibition interferes with global EWS/ETS transcriptional activity and impedes Ewing sarcoma tumor growth.
    Sankar S; Theisen ER; Bearss J; Mulvihill T; Hoffman LM; Sorna V; Beckerle MC; Sharma S; Lessnick SL
    Clin Cancer Res; 2014 Sep; 20(17):4584-97. PubMed ID: 24963049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel oncogenic mechanism in Ewing sarcoma involving IGF pathway targeting by EWS/Fli1-regulated microRNAs.
    McKinsey EL; Parrish JK; Irwin AE; Niemeyer BF; Kern HB; Birks DK; Jedlicka P
    Oncogene; 2011 Dec; 30(49):4910-20. PubMed ID: 21643012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-throughput RNAi screen in Ewing sarcoma cells identifies leucine rich repeats and WD repeat domain containing 1 (LRWD1) as a regulator of EWS-FLI1 driven cell viability.
    He T; Surdez D; Rantala JK; Haapa-Paananen S; Ban J; Kauer M; Tomazou E; Fey V; Alonso J; Kovar H; Delattre O; Iljin K
    Gene; 2017 Jan; 596():137-146. PubMed ID: 27760381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-CD99 Antibody Therapy Triggers Macrophage-Dependent Ewing Cell Death In Vitro and Myeloid Cell Recruitment In Vivo.
    O'Neill AF; Nguyen EM; Maldonado ED; Chang MR; Sun J; Zhu Q; Marasco WA
    Antibodies (Basel); 2024 Mar; 13(1):. PubMed ID: 38534214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic utility of FLI-1 monoclonal antibody and dual-colour, break-apart probe fluorescence in situ (FISH) analysis in Ewing's sarcoma/primitive neuroectodermal tumour (EWS/PNET). A comparative study with CD99 and FLI-1 polyclonal antibodies.
    Mhawech-Fauceglia P; Herrmann F; Penetrante R; Beck A; Sait S; Block AM; Odunsi K; Fisher J; Balos L; Cheney RT
    Histopathology; 2006 Dec; 49(6):569-75. PubMed ID: 17163841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BET bromodomain inhibitors suppress EWS-FLI1-dependent transcription and the IGF1 autocrine mechanism in Ewing sarcoma.
    Loganathan SN; Tang N; Fleming JT; Ma Y; Guo Y; Borinstein SC; Chiang C; Wang J
    Oncotarget; 2016 Jul; 7(28):43504-43517. PubMed ID: 27259270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ubiquitin-Specific Protease 6 Functions as a Tumor Suppressor in Ewing Sarcoma through Immune Activation.
    Henrich IC; Jain K; Young R; Quick L; Lindsay JM; Park DH; Oliveira AM; Blobel GA; Chou MM
    Cancer Res; 2021 Apr; 81(8):2171-2183. PubMed ID: 33558334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GDF6-CD99 Signaling Regulates Src and Ewing Sarcoma Growth.
    Zhou F; Elzi DJ; Jayabal P; Ma X; Chiu YC; Chen Y; Blackman B; Weintraub ST; Houghton PJ; Shiio Y
    Cell Rep; 2020 Nov; 33(5):108332. PubMed ID: 33147457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, synthesis and biological evaluation of Nucleosidic CD99 inhibitors that selectively reduce Ewing sarcoma viability.
    Balaraman K; Deniz E; Nelson E; Pilicer SL; Atasoy S; Molotkova A; Sevim H; Tiwari PB; Üren A; Wolf C
    Eur J Med Chem; 2023 May; 251():115244. PubMed ID: 36917882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macrophage infiltration predicts a poor prognosis for human ewing sarcoma.
    Fujiwara T; Fukushi J; Yamamoto S; Matsumoto Y; Setsu N; Oda Y; Yamada H; Okada S; Watari K; Ono M; Kuwano M; Kamura S; Iida K; Okada Y; Koga M; Iwamoto Y
    Am J Pathol; 2011 Sep; 179(3):1157-70. PubMed ID: 21771572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative analysis of routine histology, immunohistochemistry, reverse transcriptase polymerase chain reaction, and fluorescence in situ hybridization in diagnosis of Ewing family of tumors.
    Jambhekar NA; Bagwan IN; Ghule P; Shet TM; Chinoy RF; Agarwal S; Joshi R; Amare Kadam PS
    Arch Pathol Lab Med; 2006 Dec; 130(12):1813-8. PubMed ID: 17149955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism and relevance of EWS/FLI-mediated transcriptional repression in Ewing sarcoma.
    Sankar S; Bell R; Stephens B; Zhuo R; Sharma S; Bearss DJ; Lessnick SL
    Oncogene; 2013 Oct; 32(42):5089-100. PubMed ID: 23178492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flow cytometric detection of Ewing sarcoma cells in peripheral blood and bone marrow.
    Dubois SG; Epling CL; Teague J; Matthay KK; Sinclair E
    Pediatr Blood Cancer; 2010 Jan; 54(1):13-8. PubMed ID: 19711435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relation of neurological marker expression and EWS gene fusion types in MIC2/CD99-positive tumors of the Ewing family.
    Amann G; Zoubek A; Salzer-Kuntschik M; Windhager R; Kovar H
    Hum Pathol; 1999 Sep; 30(9):1058-64. PubMed ID: 10492040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of an Ewing sarcoma cell line with resistance to EWS‑FLI1 inhibitor YK‑4‑279.
    Conn E; Hour S; Allegakoen D; Graham G; Petro J; Kouassi-Brou M; Hong SH; Selvanathan S; Çelik H; Toretsky J; Üren A
    Mol Med Rep; 2020 Mar; 21(3):1667-1675. PubMed ID: 32016454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.